Relevant bibliographies by topics / Drug utilisation

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Drug utilisation'

Author: Grafiati
Published: 4 June 2021
Last updated: 19 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drug utilisation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drug utilisation"

1

McManus, Peter. "Drug Utilisation." Medical Journal of Australia 158, no. 10 (May 1993): 724. http://dx.doi.org/10.5694/j.1326-5377.1993.tb121949.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cooke, Jonathan. "Drug utilisation research." International Journal of Pharmacy Practice 1, no. 1 (March 1991): 5–9. http://dx.doi.org/10.1111/j.2042-7174.1991.tb00518.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baiju, Agnus, Rosmin Jacob, and K. Krishnakumar. "The Relevance of Defined Daily Dose concept in Drug Utilisation Research: A Review." Journal of Drug Delivery and Therapeutics 11, no. 4-S (August 15, 2021): 162–65. http://dx.doi.org/10.22270/jddt.v11i4-s.4897.

Full text
Abstract:
According to World Health Organisation (WHO), drug utilisation is defined as the marketing, distribution, prescription and the use of drugs in society with special focus on resulting medical, social and economic consequences and it has turned into a powerful scientific tool for ensuring the rational and cost-effective use of drugs. A standard method is required to identify and aggregate drug data. This manuscript provides an overview of the WHO Anatomical Therapeutic Chemical (ATC) classification and the associated measure, Defined Daily Dose (DDD), as a methodology for evaluating drug utilisation. Keywords: Drug utilisation research, Anatomical Therapeutic Chemical classification system, Defined Daily Dose, Rational drug use.
APA, Harvard, Vancouver, ISO, and other styles
4

Garattini, S., and G. Tognoni. "Drug Utilisation Review and Pharmacoeconomics." PharmacoEconomics 4, no. 3 (September 1993): 162–72. http://dx.doi.org/10.2165/00019053-199304030-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bergman, Ulf, and Andrew Herxheimer. "Drug utilisation research in Europe." Lancet 342, no. 8864 (July 1993): 167. http://dx.doi.org/10.1016/0140-6736(93)91359-t.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ljubojevic, Gordana, Milan Mastikosa, Tanja Dostanic-Dosenovic, Snjezana Novakovic-Bursac, Natasa Tomic, Goran Talic, Ranko Skrbic, and Milos Stojiljkovic. "Drug utilisation trends in a physical rehabilitation hospital." Vojnosanitetski pregled 76, no. 12 (2019): 1261–67. http://dx.doi.org/10.2298/vsp180118046l.

Full text
Abstract:
Background/Aim. Drug utilisation monitoring could identify drug-related problems and hence improve the awareness of irrational drug use. The objective of this study was to analyse the drug utilisation patterns in a rehabilitation hospital over the period 2011?2016. Methods. The Anatomic Therapeutic Chemical classification/Defined Daily Dose (ATC/DDD) methodology was used to monitor the drug utilisation expressed as a number of DDD per 100 patient-days (HPD). The values of DDDs were obtained from the World Health Organisation (WHO) Collaborating Centre for Drug Statistics Methodology. Utilisation trends were analysed by means of the Compound Aggregate Growth Rate (CAGR), which is defined as an average annual change rate of some value during the period of interest. Results. The number of patient-days increased during the six years period; the CAGR being1.8% annually. At the same time, the total number of dispensed DDDs as well as the number of DDD/HPD decreased with the CAGR of -2.0% and -3.7% respectively. The average drug cost per patient-day varied from BAM 1.38 in 2013 to 0.95 in 2016; the CAGR being -1.8%. The most utilised drugs belonged to the ATC groups C, A, B, M and N and they contributed to an average of 77% of all drugs used each year. On the top of the list of most utilised drugs were: hydroxocobalamin, thioctic acid, enalapril, diclofenac, amlodipine, acetylsalicylic acid, pantoprazole, paracetamol and bromazepam. Conclusions. The overall drug utilisation in the hospital was modest and almost equal in 2016 compared to 2011. Besides the leading consumption of vitamin B12 and thioctic acid, this study points out some interesting prescribing patterns, such as predominant use of diclofenac over ibuprofen, and overuse of proton pump inhibitors. There is a need for educative interventions among physicians in order to improve their prescribing practice.
APA, Harvard, Vancouver, ISO, and other styles
7

Blackburn, Jim L. "Impact of Drug Usage Review on Drug Utilisation." PharmacoEconomics 3, no. 1 (January 1993): 14–21. http://dx.doi.org/10.2165/00019053-199303010-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Velickovic-Radovanovic, Radmila, Jasmina Petrovic, Biljana Kodela, and Slobodan Janković. "Antihypertensive drugs utilisation and educational activities." Open Medicine 5, no. 5 (October 1, 2010): 627–35. http://dx.doi.org/10.2478/s11536-010-0033-6.

Full text
Abstract:
AbstractThe mortality rate from cardiovascular diseases is high in Serbia. Analysis of antihypertensive drugs utilization is the basis for assessment of cardiovascular pharmacotherapy appropriateness. The aim of this study was to analyze the trend in antihypertensive drugs utilization among outpatients in Niš region, South Serbia compared to some Nordic countries (Norvay, Sweden) and Australia as well as to analyze trends in educational and drug promotion activities directed to primary healthcare workers within the same region. Using the ATC/DDD methodology, we analyzed the utilization of antihypertensive drugs dispensed on prescription in the Nis region over the 2003–2007 period. The study was retrospective, based on data obtained from Central City Pharmacy Nis. Educational and drug promotion activities were noted from the records of Medical Faculty, University of Nis, and from the records of local branches of pharmaceutical companies active in Serbia. Wilcoxon’s test was used in order to calculate the statistical significance of difference. A significant increase of 79.8% (153.8/ 276.6 DDD/inhabitants/day) in antihypertensive drug consumption was observed in the same period. This analysis showed there were substantial increases in the use of diuretics (134.7%), ACE inhibitors (79.5%) and calcium channel blockers (116.1%), especially amlodipin (241.2%). During the observed period, annual numbers of educational activities and of pharmaceutical sales representatives employed within the region increased for almost one fourth. This analysis pointed to a significant increase in the use of antihypertensive drugs in the Nis region, which was matched with increase in educational and drug promotion activities within the region, so that in 2006–2007 total consumption was approximate to some referential countries (Norvay, Sweden).
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "OTC switches change drug utilisation patterns." Inpharma Weekly &NA;, no. 961 (October 1994): 6. http://dx.doi.org/10.2165/00128413-199409610-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Truter, I. "Appetite Suppressants: A Drug Utilisation Study." Value in Health 16, no. 7 (November 2013): A389—A390. http://dx.doi.org/10.1016/j.jval.2013.08.386.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drug utilisation"

1

Bardel, Annika. "Women's health and drug utilisation /." Uppsala : Acta Universitatis Upsaliensis, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Darwish, Dana Abdel Bari. "Cardiovascular drug utilisation in Jordanian hospitals." Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.440542.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Piovani, Daniele. "Determinants of drug utilisation during childhood." Thesis, Open University, 2018. http://oro.open.ac.uk/55058/.

Full text
Abstract:
Paediatric pharmacology is a neglected area in terms of rational use of drugs. Wide differences have been observed in children’s exposure to drugs between and within countries and regions. The aim of the current thesis is to investigate the determinants of drug prescription in paediatrics. Pharmacoepidemiology and the use of administrative databases can be a useful tool for this scope. Data collected in regional and multiregional administrative prescription databases were analysed. Prevalence data by sex and age were calculated by dividing the number of drug users by the total number of male and female residents in each age group. Univariable and multivariable analyses were performed with the aim to identify the determinants of drug prescriptions. The studies showed quantitative and qualitative differences in drug prescription to children and adolescents among Italian regions and within regions. The prescription of a great number of different, redundant, active substances, even among experienced paediatricians, was found. A North-South trend was found in antiasthmatic and antibiotic prevalence, with an important association with average income at the area level. A confirmation of the high prevalence of these drugs and poor qualitative profile was also found. Large heterogeneity was found in psychotropic drug prevalence among different Italian regions. Psychotropic drugs were scantly prescribed and some of the most used drugs were prescribed off-label. The analyses of the prescription of generic antibiotics showed that generic formulations are scantly prescribed by Italian paediatricians, and the lowest prescription rate of generic drugs was found in paediatricians who prescribe more antibiotics. Some quality indicators for antibiotic prescribing were developed at the paediatrician level. The youngest paediatricians and those who were not exposed to educational interventions showed a significantly worse quality of prescribing. The thesis provide some useful data for policy makers in order to improve the rational drug use in children.
APA, Harvard, Vancouver, ISO, and other styles
4

Grundmark, Birgitta. "Prostate Cancer; Metabolic Risk Factors, Drug Utilisation, Adverse Drug Reactions." Doctoral thesis, Uppsala universitet, Institutionen för kirurgiska vetenskaper, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-194297.

Full text
Abstract:
Increased possibilities during the last decades for early detection of prostate cancer have sparked research on preventable or treatable risk factors and on improvements in therapy. Treatments of the disease still entail significant side effects potentially affecting men during the rest of their lives. The studies of the present thesis concern different aspects of prostate cancer from etiological risk factors and factors influencing treatment to an improved methodology for the detection of treatment side effects. Papers I, II, both based in the population based cohort ULSAM (Uppsala Longitudinal Study of Adult Men), investigate possible risk factors of prostate cancer with options for intervention: selenium levels and the metabolic syndrome. The phenomenon of competing risk of death from other causes than prostate cancer and its impact on and importance for choice of statistical methods is also exemplified and discussed for the first time in prostate cancer research. -Smokers with low selenium status have an increased future risk of later development of prostate cancer. Influence of genetic variability appears plausible. -The metabolic syndrome and especially its increased waist circumference component are associated with later development of prostate cancer – taking competing risks of death from other causes into account. Papers III and IV using pharmacoepidemiological methods investigate aspects of drug utilisation in prostate cancer using nationwide and international databases. In Paper III factors influencing anti-androgen use in prostate cancer are investigated, both from a prescriber- and patient perspective.  The age and disease risk group of the patient, unsupported scientifically, influence both the prescribers’ choice of dose and the patients’ adherence to treatment. -Adherence, not previously investigated in male cancer patients, was considerably higher than reported for adjuvant breast cancer treatment. Subgroups of men suitable for intervention to increase adherence were identified. Paper IV, investigates the feasibility of improving an established method for screening large adverse drug reactions databases, the proportional reporting ratio (PRR), this by using restricted sub-databases according to treatment area (TA), introducing the concept of PRR-TA. -The PRR-TA method increases the signal-noise relationship of analyses; a finding highly relevant for possibly conserving manual resources in Pharmacovigilance work in a drug-authority setting.
APA, Harvard, Vancouver, ISO, and other styles
5

Monaghan, Mark Peter. "The turmoil of evidence : research utilisation in UK drug classification." Thesis, University of Leeds, 2008. http://etheses.whiterose.ac.uk/701/.

Full text
Abstract:
This thesis investigates the thorny relationship between evidence utilisation and policy making in a heavily politicised policy area. Expectations for the conflux of researcha nd policy formulation have been consolidated in the last decade under the banner of 'evidence-based policy'. In recent times, the debateo ver the nature and utility of evidence-based policy has become much more sophisticated. No longer can the connection between evidence utilisation and policy formulation be conceived in terms of evidence shaping policy outcomes or, conversely, policy being evidence free, where evidence has no impact. Such conceptualisations persist, however, in heavily politicised policy areas, where there is intense media scrutiny of decision making, a lack of consensus on its direction, prolonged conflict between competing interest and stakeholder groups and a permeating sense of crisis. These tend to relate to more 'macro' policy areas, not usually the remit of evidence-based policy-making and evaluative research. Using recent and ongoing developments in UK drug classification policy as a case-study, an explanatory framework of the complex role and nature of evidence in heavily politicised policy areas is developed. Central to this, is the use of a methodological approach that can account for the role of conflict in the policy process. A modified version of the Advocacy Coalition Framework is employed to this end. This, in turn, allows for a range of data-collection methods to be used, including observation and documentary analysis of Parliamentary Select Committee hearings alongside qualitative interviews with a wide-range of key policy actors involved in the decision-making process. From this a nuanced account of the evidence and policy relationship in such contexts is ascertained,which departs from the more established models explaining the evidence and policy nexus. Traditionally, such explanations have been conceived as models of research utilisation. In this research it is suggested that these do not translate effectively as models of evidence-based policy-making. This is because they are beset with some, or all, of the following problems: a) they focus more on 'research' rather than the broader concept of 'evidence'; b) they operate with a static view of the policy process where there is a direct connection between research and policy; c) they restrict the role of evidence to one of policy outcomes, rather than viewing the role of evidence in the process of decision-making; d) they assume that research is the defining influence on the decision-making processe; e) they operate at a high level of abstraction, offering little account of how research is selected for use in decision making. Consequently, a newer addition to the literature is developed, which, it is claimed, avoids these shortcomings.
APA, Harvard, Vancouver, ISO, and other styles
6

Bardel, Annika. "Women's Health and Drug Utilization." Doctoral thesis, Uppsala University, Department of Public Health and Caring Sciences, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8225.

Full text
Abstract:

Objectives. To study medication utilization and adherence to prescribed therapy in a female population in central Sweden. To study usage of hormone replacement therapy (HRT) in this population and to assess how HRT users compare to non-users regarding symptom reporting, general health and other variables. To evaluate symptom prevalence adjusted for potential symptom affecting variables.

Material and methods. A cross-sectional postal questionnaire study was performed in 1995 in seven counties in central Sweden. A questionnaire was sent to a random sample of 4,200 women aged 35-64, of whom 2,991 responded (71.2%). The questionnaire contained questions on psycho-socio-economic background, quality of life, self-reported health, height and weight, climacteric symptom prevalence, and menopausal status and symptoms. It also comprised questions on medication prescribed during the past year.

Results. 40% used prescribed medication and 12% took four drugs or more. Age, educational level, self-rated health, and BMI remained significantly correlated to drug use in multivariate analysis. Adherence ranged from 15%-98% depending on age, a scheduled check-up, perceived importance of medication, concern about medication, taking cardiovascular and respiratory disease drugs. The highest adherence was found for hormonal medication the lowest for musculoskeletal medication.

HRT was used by 15% of the women. 13 % used other symptom relieving therapy. HRT users reported higher score of vasomotor symptoms, except for sweating during the daytime.

Prevalence of general symptoms did not necessarily increase with age. Especially symptoms related to stress-tension-depression decreased with age. Four different symptom prevalence patterns were found.

Conclusions. Age, health status, educational level and body mass index (BMI) appear to affect drug use. Adherence to therapy is highest among elderly women who regard their medication as important and have a scheduled check-up. HRT relieves some vasomotor symptoms but does not affect other symptoms or self-rated health. Prevalence of symptoms related to Stress-tension-depression appears to decrease with age.

APA, Harvard, Vancouver, ISO, and other styles
7

Wright, Alison Katrina. "Examining drug utilisation patterns and optimal treatment pathways of antidiabetic medications." Thesis, University of Manchester, 2015. https://www.research.manchester.ac.uk/portal/en/theses/examining-drug-utilisation-patterns-and-optimal-treatment-pathways-of-antidiabetic-medications(bfef381c-583d-4747-9b8e-44cb904f48a2).html.

Full text
Abstract:
Background: Type 2 Diabetes is a chronic metabolic condition which occurs as a result of insufficient insulin production and insulin resistance. This results in less glucose uptake by muscle and fat cells, allowing blood glucose levels to rise in the body. Higher blood glucose levels place patients at an increased risk of diabetes-related complications. The treatment is characterised by the initiation, switching and intensification of antidiabetic medications. The goal for patients with diabetes is to maintain glycaemic control, with blood glucose levels (HbA1c) between 6.5-7.0%(48-53mmol/mol). International guidelines recommend prescribing of metformin at initiation but there is no consensus on optimal agents in a combination regimen. The aim of this thesis was to assess the drug utilisation patterns of first-line therapies and the impact of this pathway on second-line regimens. This entailed: (i.) observing the prescribing of the first-line therapy, (ii.) characterising the medication-taking process of the first-line therapy and effectiveness of the regimens, and (iii.) determining the most effective second-line regimen in delaying the onset of microvascular complications. Methods: Patients with type 2 diabetes, prescribed a first-line antidiabetic regimen, were identified from the Clinical Practice Research Datalink (a large UK anonymised primary care database) between 01/01/05 and 31/12/09, were followed-up until 31/12/12. A multinomial logistic regression model was used to assess the relationship between patient characteristics and the choice of first-line agent. Adherence to first-line therapy was estimated using the Medication Possession Ratio calculation, expressing the percentage of days covered by a drug supply. To assess the factors influencing achievement of glycaemic goals from the first-line therapy, a logistic regression analysis was performed. To investigate second-line regimens, a Marginal Structural Cox model was implemented to explore the causal relationships between the time to development of microvascular complications and the second-line regimens. Results: Of the 72,429 individuals diagnosed with type 2 diabetes, 44,838 started therapy with an antidiabetic medication regimen. Metformin and sulphonylureas were the most frequently prescribed agents at initiation (82.9% and 9.8%,respectively). Deviations from metformin were associated with patients presenting with higher HbA1c levels, lower BMI values and had concurrent prescriptions (immunosuppressants and oral corticosteroids). Achieving glycaemic control, to the target of 6.5% (48mmol/mol), was only met in 22.7% of patients. Characteristics of the patient, choice of first-line agent and medical support influenced the effectiveness of the treatments. Patients at the greatest risk of failing to achieve the target glycaemic goal from therapy had HbA1c levels>8.0% (64mmol/mol) and a BMI≥25kg/m2. Adherence was significantly associated with greater lowering of HbA1c levels but these reductions did not guarantee reaching the ideal glycaemic target. Intensification of the monotherapy to a dual therapy regimen was observed in 30.2% of patients in a mean time of 2 years. The most frequently prescribed second-line regimens consisted of metformin/sulphonylurea (SU) (74.5%), metformin/thiazolidinediones(TZD) (11.3%) and metformin/DPP-4 inhibitors (14.2%). Metformin/SU was the most effective dual therapy regimen for delaying the onset of microvascular diagnoses. The rate of development of these events was significantly higher for the DPP-4 combination in comparison to the SU combination with a hazard ratio of 1.85 (95% CI: 1.53,2.24). A TZD combination resulted in a non-significant increase of 19% in the rate of development compared to the SU combination (HR 1.19; 95% CI: 0.98,1.47). Metformin/SU resulted in the greatest lowering in HbA1c levels (-3.3%; 12mmol/mol) in comparison to the DPP-4 and TZD regimens. Conclusions: It is unlikely that patients starting first-line therapy with high HbA1c levels will be able to reduce blood glucose levels sufficiently on a monotherapy regimen. It is important for practitioners to consider a faster uptake of a dual therapy regimen (metformin/SU) to prevent sustained suboptimal glycaemic control and reduce the risk of future complications. Other important considerations in the optimal treatment pathway would be to provide more frequent support from health professionals; this may help to highlight inadequate drug regimens, offer management of risk factors and provide education. These aspects may help patients to achieve better control of their condition, with the aim of reducing the risk of diabetes-related complications; which, severely impact patient quality of life and NHS costs and resources.
APA, Harvard, Vancouver, ISO, and other styles
8

Burger, Solé. "A drug utilisation review of Isotretinoin in the management of acne." Thesis, Nelson Mandela Metropolitan University, 2007. http://hdl.handle.net/10948/673.

Full text
Abstract:
Acne is a common, chronic disorder that affects many adolescents. The most effective acne medication is systemic isotretinoin. It provides a permanent cure for many patients, but has various side effects. A South African Acne Treatment Guideline was introduced in 2005. Adherence to this guideline could lead to safer, more effective acne management. The primary aim of this study was to investigate the appropriateness of medications prescribed in the treatment of acne in South Africa, and to evaluate the safety and efficacy of systemic isotretinoin utilised by patients in the Nelson Mandela Metropole (NMM). A drug utilisation study (including 18 803 South African acne patients’ chronic prescription data between 2000 and 2005) and a patient questionnaire survey (including information from 57 patients in the NMM who used systemic isotretinoin) were conducted. Basic descriptive and interferential statistics were calculated. The drug utilisation study revealed that systemic antibiotics were the acne treatment prescribed to most (43.3 percent) patients, followed by 42.1 percent of patients on systemic isotretinoin, 33.2 percent on hormonal therapy and 18.9 percent on topical therapy. Topical retinoids were underused. The questionnaire survey indicated a lack of compliance by prescribers with guideline recommendations regarding the prescription (and accompanying counselling and monitoring) of isotretinoin. Incorrect cumulative doses were frequently prescribed, and a lack of proper implementation of pregnancy prevention measures was evident. The majority of isotretinoin patients reported a high efficacy of isotretinoin in clearing their acne.
APA, Harvard, Vancouver, ISO, and other styles
9

Larsson, Mattias. "Antibiotic use and resistance : assessing and improving utilisation and provision of antibiotics and other drugs in Vietnam /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-630-8/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hedna, Khedidja. "Inappropriate prescribing, non-adherence to long-term medications and related morbidities : Pharmacoepidemiological aspects." Doctoral thesis, Linköpings universitet, Avdelningen för läkemedelsforskning, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-122266.

Full text
Abstract:
Background: Inappropriate use of medications (IUM), in particular inappropriate prescribing and non-adherence to prescribed medications, are important causes of drug-related morbidities (DRMs). They are increasing problems with the ageing populations and the growing burden of chronic conditions. However, research is needed on the association of IUMs with DRMs in outpatient settings and in the general population. Aim: The aim of this thesis is to estimate and analyse the burden of potentially inappropriate prescriptions (PIPs) in the elderly and non-adherence to long-term medications among adults across care settings, and to investigate how IUM is associated to DRMs. Methods: A meta-analysis summarised the previous evidence on the percentage of adverse drug reactions (ADRs) associated to IUM across healthcare settings (Study I). From a cohort in the general population, using medical records and register data, the prevalence of PIPs in the elderly and its association with ADRs were estimated retrospectively (Study II). From the same cohort, the factors associated with refill non-adherence to antihypertensive therapy, considering the use of multiple medications, and the association between non-adherence and sub-therapeutic effects (STEs) were investigated (Study III). A survey assessed the refill behaviour to antihypertensive, lipid lowering and oral antidiabetic medications (undersupply, adequate supply and oversupply), and its association with perceived ADRs and STEs (Study IV). Results: IUM was the cause 52% and 45% of ADRs occurring in adult outpatients and inpatients respectively. Across healthcare settings, 46% of the elderly refilled PIPs over a 6-month period; PIPs were considered the cause of 30% of all ADRs; and the elderly who were prescribed PIPs had increased odds to experience ADRs (OR 2.47, 95% CI 1.65-3.69). In total, 35% was nonadherent to the full multidrug therapy and 13% was non-adherent to any medication (complete non-adherence).  Sociodemographic factors (working age and lower income) were associated with non-adherence to any medication, while clinical factors (use of specialised care, use of multiple medications, and being a new user) with non-adherence to the full multidrug therapy. STEs were associated with non-adherence to any medication a month prior to a healthcare visit (OR 3.27, 95% CI 1.27-8.49), but not with long-term measures of non-adherence. Among survey respondents, 22% of the medications were oversupplied and 12% were undersupplied. Inadequate refill behaviour was not associated with reporting ADRs or STEs (p<0.05). Conclusions: A large proportion of ADRs occurring in hospital is caused by IUM, but more knowledge is needed in other settings. PIPs are common in the elderly general population and associated with ADRs. Therefore decreasing PIPs could contribute towards ADR prevention. Considering the use of multiple medications may help to better understand the factors associated with non-adherence to a multidrug therapy for tailoring the interventions to patient needs. Monitoring the adherence prior to a healthcare visit may facilitate interpreting STEs. Yet, the absence of an association between long-term measures of refill non-adherence with clinical and perceived DRMs suggest the need to enhance the knowledge of this association in clinical practice. In summary, this thesis shows a significant potential for improvements of medication use and outcomes.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drug utilisation"

1

Pérodeau, Guillème Marcelle. Adaptation au stress et utilisation des psychotropes par les personnes âgées. Hull, Québec: Université du Québec à Hull, Dép. des sciences humaines, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kumar, Pradeep. Medicinal plants in India: Conservation and sustainable utilisation in the emerging global scenario. Dehra Dun: Bishen Singh Mahendra Pal Singh, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kumar, Pradeep. Medicinal plants in India: Conservation and sustainable utilisation in the emerging global scenario. Dehra Dun: Bishen Singh Mahendra Pal Singh, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schlaadt, Richard G. Drugs of choice: Current perspectives on drug use. 2nd ed. Englewood Cliffs, N.J: Prentice-Hall, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reuter, Peter. Sealing the borders: The effects of increased military participation in drug interdiction. Santa Monica, CA: Rand Corp., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Medicinal Plants in India ; Conservation and Sustainable Utilisation in the Emerging Global Scenario. Daya Publishing House, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Claudine, Laurier, and Enquête Santé Québec 87, eds. L' Utilisation des tranquillisants, sédatifs et somnifères: Analyse des données de l'Enquête Santé Québec. Québec: Gouverenement du Québec, Ministère de la santé et des services sociaux, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Québec (Province). Ministère de la santé et des services sociaux. Direction de l'évaluation., ed. L' utilisation rationnelle des médicaments chez les personnes âgées: Stratégie d'action : recueil des documents de travail. [Québec]: Gouvernement du Québec, Ministère de la santé et des services sociaux, Direction de l'évaluation, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

L' utilisation des médicaments chez les personnes âgées: Actes du colloque tenu au Château Frontenac, à Québec le 27 mai 1993. [Québec]: Gouvernement du Québec, Le Ministère, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Randy, Vogenberg F., ed. Introduction to applied pharmacoeconomics. New York: McGraw-Hill, Medical Pub. Division, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Drug utilisation"

1

Nahler, Gerhard. "drug utilisation study." In Dictionary of Pharmaceutical Medicine, 59. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_447.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nahler, Gerhard. "drug utilisation review (DUR)." In Dictionary of Pharmaceutical Medicine, 59. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_446.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Godman, Brian, Joseph Fadare, Dan Kibuule, Lyna Irawati, Mwangana Mubita, Olayinka Ogunleye, Margaret Oluka, et al. "Initiatives Across Countries to Reduce Antibiotic Utilisation and Resistance Patterns: Impact and Implications." In Drug Resistance in Bacteria, Fungi, Malaria, and Cancer, 539–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48683-3_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Liverani, Marco, Lauren Oliveira Hashiguchi, Mishal Khan, and Richard Coker. "Antimicrobial Resistance and the Private Sector in Southeast Asia." In Ethics and Drug Resistance: Collective Responsibility for Global Public Health, 75–87. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-27874-8_5.

Full text
Abstract:
Abstract Southeast Asia is considered a regional hotspot for the emergence and spread of antimicrobial resistance (AMR). A commonality across countries in the region, particularly those with lower incomes such as Cambodia, Myanmar, Lao PDR and Vietnam, is the high utilisation of private healthcare providers, often unregulated, which may play a role in driving AMR. In this chapter we discuss challenges to the control of AMR in Southeast Asia, with a focus on the role of the private sector. After providing an overview of the problem and current policy responses, we consider ethical issues of equity and fairness that may arise from the implementation of established and proposed interventions.
APA, Harvard, Vancouver, ISO, and other styles
5

Alam, Moneer. "Utilisation of Public Health Facilities: A Situational Assessment." In Paying Out-of-Pocket for Drugs, Diagnostics and Medical Services, 121–40. New Delhi: Springer India, 2013. http://dx.doi.org/10.1007/978-81-322-1281-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alam, Moneer. "Self-Reported Ailments and Hospitalisation: Differentials in Utilisation of Health Care." In Paying Out-of-Pocket for Drugs, Diagnostics and Medical Services, 79–83. New Delhi: Springer India, 2013. http://dx.doi.org/10.1007/978-81-322-1281-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Trim, Carol M., Lee J. Byrne, and Steven A. Trim. "Utilisation of compounds from venoms in drug discovery." In Progress in Medicinal Chemistry, 1–66. Elsevier, 2021. http://dx.doi.org/10.1016/bs.pmch.2021.01.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Monaghan, Mark. "The utilisation of evidence in a politicised policy area." In Evidence versus politicsExploiting research in UK drug policy making?, 110–28. Policy Press, 2011. http://dx.doi.org/10.1332/policypress/9781847426970.003.0007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

N. Mohite, Prashant, Kavita Dave, Anna Reed, and André R. Simon. "Lung Transplantation in Patients with Cystic Fibrosis." In Cystic Fibrosis - Facts, Management and Advances. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.94523.

Full text
Abstract:
Cystic fibrosis (CF) is one of the most common indications for lung transplant (LTx) and nearly one-third of the LTx worldwide are performed in people with CF (PwCF). Due to vast developments in diagnostic modalities, antibiotic therapies, and management of associated comorbidities in dedicated and experienced centres, over the past few decades, more PwCF are reaching adulthood than ever before. This has increased the burden on transplant programs particularly in a universal donor shortage scenario. To improve the donor pool a diligent and proactive donor care management, acceptance of marginal organs and utilisation of ex-vivo lung perfusion systems for organ preservation, assessment, and improvement is being advocated widely. LTx is not a readily available therapy and the average waiting time is 18 months in the UK. Therefore, it is essential that PwCF are referred for LTx assessment when their disease is stable, before respiratory deterioration leads to overall deconditioning of the patients. Once listed for LTx, it is crucial to control waiting list mortality by prioritising rapidly deteriorating patients through schemes like the lung allocation score, national urgent and super-urgent waiting lists, and institutional highlighting of deteriorating patients that do not meet other urgent criteria. LTx in PwCF is challenging due to colonisation of the respiratory tract with multi-drug resistant organisms, associated comorbidities such as diabetes, liver disease, gastro-oesophageal reflux, and distal intestinal obstruction syndrome (DIOS) and CF-specific technical difficulties (adhesions due to prior pneumothoraces or pleurodesis, or bronchial collaterals that increase surgical time). Hilar lymphadenopathy and bronchial collaterals may increase surgical time, organ ischemia time, intra and post-operative bleeding, and blood transfusions. Advances in immunosuppression, prophylactic anti-viral and anti-fungal therapies, early ambulation and rigorous physiotherapy, and meticulous postoperative follow up with spirometry, x-rays, and bronchoscopies to detect rejection at the early stage followed by its efficient treatment have helped to improve post-LTx survival in the CF patients. Constant development in the surgical field with adoption of off-pump transplantation, sternal sparing bilateral thoracotomy approach, and utilisation of mechanical circulatory assist as a bridge to transplant and as a support for primary graft failure strives for better outcomes. However, chronic lung allograft dysfunction, chronic refractory infections, malignancies, and CF associated comorbidities remain major determinants of post-LTx long term survival. Despite this, CF patients are often good candidates for re-do LTx with improving survival outcomes. In this chapter, we are compiling the different aspects of LTx in PwCF emphasising the advances in bridge to transplantation, the surgical approach, management of primary graft failure, and immunosuppression as well as complications post-transplant.
APA, Harvard, Vancouver, ISO, and other styles
10

Costa-Font, Joan, and Azusa Sato. "Cultural Attitudes and the “Traditional Medicines Paradox”: Evidence from Ghana and the Philippines." In Social Economics. The MIT Press, 2017. http://dx.doi.org/10.7551/mitpress/9780262035651.003.0011.

Full text
Abstract:
Traditional medicines continue to be widely used worldwide despite the increasing availability of modern medicines. We term this phenomenon the ‘traditional medicines paradox’. We investigate a potential explanation for such a paradox, namely the presence of ‘entrenched cultural beliefs’ in explaining continued use. As such, this paper draws upon unique data collected in Ghana to examine the impact of 6 attitudes towards traditional medicines and healers on utilisation. To further test the importance of attitudes, we look at data from the Philippines. In both cases, cultural attitudes such as perceived healer knowledge, trust, belief in ability to cure, and acceptability are found to be significantly associated with utilisation. Hence it is unlikely that traditional medicines will be supplanted simply by increasing access to modern drugs as they are not perceived to be substitutes and the systems exhibit divergent logic.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drug utilisation"

1

Kim, H., S. Min, S. Yu, Y. Jung, and H. Jeong. "4CPS-233 Analysis of drug prescriptions of incompatible drugs through drug utilisation review." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Murphy, D., M. Kieran, and J. Brown. "4CPS-343 Pregabalin and gabapentin drug utilisation review." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baan, Esmé J., Astrid Heeremans, Leila Karimi, Guy G. Brusselle, Miriam Sturkenboom, Johan De Jongste, Lies Lahousse, Hettie M. Janssens, and Katia Verhamme. "Patterns of drug utilisation over age in asthmatic children." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa5426.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Celma, M. Sánchez, F. Bossacoma Busquets, JL Vinent Genestar, J. Arrojo Suárez, M. Villaronga Flaqué, A. Comes Escoda, V. Santa-María López, and P. Montoliu Alcón. "6ER-011 Drug utilisation study of bevacizumab in a teaching referral paediatric hospital." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wood, Sarah, Kimme Hyrich, Suzanne Verstappen, and Douglas Steinke. "THU0200 DRUG UTILISATION IN PEOPLE WITH EARLY RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.4721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ramos, J. Cordero, MD Alvarado Fernández, S. Santana Martínez, M. Murillo Izquierdo, and MD Guerrero Aznar. "DI-094 Botulinum toxin type a for the treatment of neurological diseases: drug utilisation review." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.341.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Busquets, F. Bossacoma, M. Sánchez Celma, J. Arrojo Suárez, A. Comes Escoda, A. Mas Comas, and A. Deya Martínez. "CP-107 Drug utilisation study of human normal immunoglobulin in immunodeficient patients in a tertiary paediatric hospital." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Busquets, F. Bossacoma, JL Vinent Genestar, A. Ruiz Llobet, VP Celis Passini, N. Arranz Pasqual, A. Comes, J. Arrojo Suárez, and M. Sácnhez Celma. "5PSQ-053 Drug utilisation study of human normal immunoglobulin in haematological and oncologic patients in a teaching paediatric hospital." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ryan, Katie. "Supporting the development of students in the pharmacy profession through stakeholder engagement and technology innovation." In Learning Connections 2019: Spaces, People, Practice. University College Cork||National Forum for the Enhancement of Teaching and Learning in Higher Education, 2019. http://dx.doi.org/10.33178/lc2019.37.

Full text
Abstract:
Pharmacists are experts in safe drug usage, and are uniquely placed to provide professional advice on a range of health related issues. It is crucial that pharmacy education embodies an emphasis on creating independent and responsible learners and prioritises life-long learning in the face of rapid change. Consequently, appropriate teaching and learning modalities are essential to prepare students. Changes in the way patient’s access information and education of pharmacists call for new ways of teaching to prepare pharmacists for a changing profession. The aim of this body of work was to support pharmacy students’ education as teachers and learners through their utilisation of technology to create short educational videos on a range of topics intended for different stakeholder groups including patients and allied healthcare professionals.
APA, Harvard, Vancouver, ISO, and other styles
10

Orlando, V., V. M. Monetti, F. Guerriero, V. Russo, A. Moretti, A. Piscitelli, R. Piscitelli, G. Iolascon, and E. Menditto. "THU0504 Utilisation of anti-osteoporotic drugs in real-world data: a study of gender-related differences." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.5572.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Drug utilisation' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography